Editorial
doi: 10.1056/NEJMe2109010.
Pimavanserin in Dementia-Related Psychosis
Affiliations
- PMID: 34289282
- DOI: 10.1056/NEJMe2109010
Item in Clipboard
Editorial
Pimavanserin in Dementia-Related Psychosis
N Engl J Med.
.
No abstract available
Comment on
-
Trial of Pimavanserin in Dementia-Related Psychosis.N Engl J Med. 2021 Jul 22;385(4):309-319. doi: 10.1056/NEJMoa2034634. N Engl J Med. 2021. PMID: 34289275 Clinical Trial.
Similar articles
-
Pimavanserin and dementia-related psychosis: can HARMONY prevail?Lancet Neurol. 2021 Oct;20(10):783-784. doi: 10.1016/S1474-4422(21)00257-X. Epub 2021 Aug 12. Lancet Neurol. 2021. PMID: 34390645 No abstract available.
-
Pimavanserin and dementia-related psychosis.Lancet Neurol. 2022 Feb;21(2):114-115. doi: 10.1016/S1474-4422(21)00466-X. Lancet Neurol. 2022. PMID: 35065031 No abstract available.
-
Pimavanserin for Psychosis in Parkinson's Disease-Related Disorders: A Retrospective Chart Review.Drugs Aging. 2019 Jul;36(7):647-653. doi: 10.1007/s40266-019-00655-y. Drugs Aging. 2019. PMID: 30924099 Free PMC article.
-
Pimavanserin, a novel antipsychotic for management of Parkinson's disease psychosis.Expert Rev Clin Pharmacol. 2017 Nov;10(11):1161-1168. doi: 10.1080/17512433.2017.1369405. Epub 2017 Oct 17. Expert Rev Clin Pharmacol. 2017. PMID: 28817967 Review.
-
Pimavanserin: novel pharmacotherapy for Parkinson's disease psychosis.Expert Opin Drug Discov. 2018 Jan;13(1):103-110. doi: 10.1080/17460441.2018.1394838. Epub 2017 Oct 31. Expert Opin Drug Discov. 2018. PMID: 29047301 Review.
Cited by
-
Pimavanserin: A Truly Effective Treatment for Parkinson's Disease Psychosis? A Review of Interventions.Neuropsychiatr Dis Treat. 2023 May 30;19:1303-1312. doi: 10.2147/NDT.S371641. eCollection 2023. Neuropsychiatr Dis Treat. 2023. PMID: 37274140 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
